BlossomHill Therapeutics, Inc. BLSM
Set alert
12.42 USD -1.33 -9.67%
At close · Nov 2
12.42 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
12.28 Day range 14.23
12.28 52-week range 27.99
- YTD
- -22.38%
- 1 year
- -22.38%
- Open
- 13.80
- Prev close
- 13.75
- Mkt cap
- 394.77M
- Vol
- 140.76K
- Avg vol
- 226.76K
- EPS
- -4.70
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 12.28
- High
- 14.23
MAX chart
Signals (138)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 30, 2026 | 3 days ago |
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| SMA: Bearish | Oct 29, 2026 | 4 days ago |
| MACD: Sell Signal | Oct 29, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 29, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bearish | Oct 27, 2026 | 6 days ago |
| MACD: Sell Signal | Oct 27, 2026 | 6 days ago |
| SMA: Bearish | Oct 27, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Oct 20, 2026 | 1 week ago |
Newest 20 of 138.
Financial health
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 2
Valuation
P/E -7.7×
FY 2024 5y median -11.4× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B -3.5×
FY 2024 5y median -5.0× FY 2025
P/FCF -9.7×
FY 2024 5y median -12.2× FY 2025
EV/EBITDA -5.5×
FY 2024 5y median -7.8× FY 2025
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2025
FCF Yield -10.3%
FY 2024 5y median -8.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2025
ROE 46.0%
FY 2024 5y median 44.0% FY 2025
ROIC -43.4%
FY 2024 5y median -39.8% FY 2025
ROA -37.2%
FY 2024 5y median -33.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income -75.9%
FY 2024 FY 2025
EPS (diluted) -96.2%
FY 2024 FY 2025
Free Cash Flow -52.3%
FY 2024 FY 2025
Financial Health
Current Ratio 9.0×
FY 2024 5y median 12.2× FY 2025
Quick Ratio 9.0×
FY 2024 5y median 12.2× FY 2025
Debt / Equity -0.2×
FY 2024 5y median -0.1× FY 2025
Net Debt / EBITDA 1.8×
FY 2024 5y median 2.3× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31